Accardi Mario Alberto 4
4 · Centessa Pharmaceuticals plc · Filed Jun 25, 2025
Insider Transaction Report
Form 4
Accardi Mario Alberto
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-06-24$14.00/sh−15,000$210,000→ 216,485 total - Exercise/Conversion
Ordinary Shares
2025-06-24$3.85/sh+15,000$57,750→ 231,485 total - Exercise/Conversion
Share Option (right to buy)
2025-06-24−15,000→ 15,300 totalExercise: $3.85Exp: 2033-02-01→ Ordinary Shares (15,000 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.